How should I evaluate and manage a 51-year-old woman with systemic lupus erythematosus (SLE) treated for 1.5 years, a history of episodic leukocytosis and fluid‑responsive acute kidney injury, and current use of turmeric, who now presents with burning bilateral lower abdominal pain and a clear thick vaginal discharge?

Immediate Evaluation for Lupus Cystitis and Gynecologic Infection

This patient requires urgent evaluation for lupus cystitis—a rare but specific SLE manifestation that presents with burning abdominal/pelvic pain, urinary symptoms, and can cause acute kidney injury—alongside concurrent assessment for cervicitis or vaginitis given the vaginal discharge.

Priority Clinical Assessment

Your immediate workup should focus on:

Urologic evaluation:

• Urinalysis with microscopy and culture
• Post-void residual volume measurement
• Renal function (creatinine, BUN) to assess current kidney status
• Bladder ultrasound to evaluate bladder wall thickening and capacity
• Consider cystoscopy if bladder capacity is markedly reduced (<100 mL)

Lupus cystitis is a specific clinical entity that presents with severe urinary frequency, suprapubic/lower abdominal pain, and reduced bladder capacity, often accompanied by hydroureteronephrosis and acute renal failure 1. The bilateral burning abdominal pain in your patient's lower abdomen is highly suspicious for this diagnosis.

Gynecologic evaluation:

• Pelvic examination with speculum exam
• Vaginal discharge microscopy (wet mount, KOH prep)
• Cervical cultures for gonorrhea, chlamydia, and other pathogens
• Pregnancy test (critical in reproductive-age women with SLE)

The clear, thick vaginal discharge suggests either physiologic discharge, cervicitis, or candidiasis—the latter being more common in immunosuppressed patients.

Disease Activity Assessment

Check lupus serologies immediately:

• Anti-dsDNA antibodies
• Complement levels (C3, C4, CH50)
• Complete blood count (assess current leukocytosis)
• Urinalysis for proteinuria and cellular casts

Her episodic leukocytosis and AKI pattern suggests recurrent lupus flares. Active SLE significantly increases risk for complications and requires aggressive immunosuppression 2.

Critical Management Decisions

If lupus cystitis is confirmed:

• Initiate high-dose corticosteroids (typically methylprednisolone 500-1000 mg IV daily for 3 days, then oral prednisone 1 mg/kg/day)
• Consider urinary diversion (nephrostomy tubes) if severe hydroureteronephrosis is present 1
• Ensure adequate hydration to prevent further AKI
• Add or optimize immunosuppression (mycophenolate or cyclophosphamide)

Regarding her turmeric use: While turmeric shows some promise for reducing SLE disease activity in preliminary studies 3, it is insufficient as monotherapy and should not replace evidence-based immunosuppression. She must be started on hydroxychloroquine immediately if not already taking it—this is foundation therapy for all SLE patients and reduces disease flares, improves pregnancy outcomes, and decreases long-term damage 2, 4.

Common Pitfalls to Avoid

1. Missing lupus cystitis: This rare manifestation (presenting in <1% of SLE patients) can be the sole manifestation of a lupus flare without typical SLE symptoms 1. The combination of lower abdominal pain, urinary symptoms, and AKI in an SLE patient should trigger immediate consideration of this diagnosis.

2. Attributing symptoms solely to infection: While concurrent infection must be ruled out (especially given her immunosuppressed state), the bilateral nature of pain and history of recurrent AKI suggest autoimmune etiology.

3. Inadequate immunosuppression: Her reliance on turmeric alone indicates she is likely undertreated. The episodic leukocytosis and AKI episodes over 1.5 years suggest inadequately controlled disease activity.

4. Delaying imaging: If bladder capacity is severely reduced or hydroureteronephrosis is present, urgent urologic intervention may be needed to prevent irreversible renal damage.

Immediate Next Steps

1. Admit for IV hydration and monitoring
2. Obtain imaging (renal/bladder ultrasound or CT urogram)
3. Start empiric broad-spectrum antibiotics pending cultures (given infection risk in immunosuppressed patients)
4. Consult rheumatology urgently for immunosuppression optimization
5. Consult urology if reduced bladder capacity or hydronephrosis confirmed
6. Treat gynecologic infection based on examination findings

The key is recognizing that burning bilateral lower abdominal pain in an SLE patient with recurrent AKI is lupus cystitis until proven otherwise, requiring aggressive immunosuppression rather than symptomatic management alone.